Orkambi: Drugs maker says NHS 'undervalues' patient lives
The manufacturer of a groundbreaking cystic fibrosis drug has accused the NHS of "undervaluing" the lives of patients after failing to reach a supply deal.
The full article is no longer available.
');
//-->